+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioid Narcotics Market - Global Forecast 2026-2032- Product Image
Opioid Narcotics Market - Global Forecast 2026-2032- Product Image
Sale

Opioid Narcotics Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142780
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Opioid Narcotics Market is projected to reach USD 32.80 Billion in 2026. It is expected to continue growing at a CAGR of 8.32%, reaching USD 53.52 Billion by 2032.

Opioid Narcotics: Executive Summary and Scope

Opioid narcotics include prescription analgesics, treatments for opioid use disorder, and illicit or diverted substances that act on opioid receptors. This executive summary examines the market through the lenses of clinical need, public-health policy, access, regulation, supply-chain integrity, and responsible innovation. It does not provide market estimates, forecasts, market shares, or company comparisons.

Public-Health Priorities Are Reshaping the Opioid Landscape

The landscape is shifting from pain treatment alone toward balanced management of analgesic access, dependence risk, overdose prevention, and recovery. Tighter prescribing controls, prescription-monitoring systems, tamper-resistant formulations, naloxone availability, and expanded treatment pathways are influencing demand and operating requirements. At the same time, inequitable access to pain care and evidence-based treatment remains a central challenge, particularly where health systems lack trained providers, reliable supply, or integrated behavioral-health services.

Artificial Intelligence Supports Safer, More Coordinated Decisions

Artificial intelligence can strengthen opioid stewardship by identifying potentially unsafe prescribing patterns, supporting clinical decision-making, improving inventory visibility, and helping public-health agencies detect changing overdose risks. Its value depends on representative data, transparent validation, privacy safeguards, and clinician oversight. Poor-quality or incomplete records may amplify bias, while automated alerts can create alert fatigue or inappropriate denial of care; therefore, AI should support-not replace-professional judgment and patient-centered assessment.

Regional Insights: Uneven Access, Regulation, and Risk

North America remains shaped by overdose prevention, treatment access, prescription oversight, and the need to address illicitly manufactured opioids. Latin America faces differing regulatory capacity, uneven availability of pain medicines, and challenges in monitoring diversion and treatment access. Europe combines established medicines regulation with varied national approaches to prescribing, harm reduction, and dependence care. The Middle East and Africa contend with both under-treatment of pain and limited access to evidence-based dependence services. Asia-Pacific presents substantial diversity, ranging from advanced monitoring and clinical infrastructure to significant gaps in controlled-medicine availability, workforce capacity, and rural access.

Group Insights: Policy Alignment and Health-System Capacity

ASEAN countries face cross-border supply-chain, regulatory, and access differences that make coordinated surveillance and professional training important. BRICS members reflect wide variation in treatment capacity, pharmaceutical regulation, and public-health burden, creating opportunities for shared research and scalable care models. The European Union benefits from common regulatory structures while national implementation and service access remain uneven. G7 members generally have mature surveillance and clinical systems but continue to address overdose prevention, affordability, and treatment gaps. GCC countries are balancing controlled-medicine stewardship with expanding clinical services. NATO members require resilient medical supply chains, interoperable emergency responses, and preparedness for substance-related health risks affecting both civilian and service populations.

Country Insights: Diverse Priorities Across Major Health Systems

Australia is emphasizing overdose response, prescribing stewardship, and treatment access across dispersed communities. Brazil faces regional disparities in care, monitoring, and harm-reduction implementation. Canada continues to address toxic illicit supplies, treatment continuity, and access outside major urban centers. China is focused on controlled-medicine regulation, clinical pain management, and prevention. France, Germany, Italy, and Spain are strengthening coordinated approaches to prescribing, dependence treatment, and surveillance within their broader European frameworks. India must balance substantial unmet pain-treatment needs with stewardship and access to treatment for dependence. Japan is managing an aging population, clinical pain needs, and cautious controlled-medicine governance. Mexico faces cross-border trafficking pressures alongside uneven access to prevention and treatment. Russia’s context includes strict controlled-substance governance and challenges in maintaining comprehensive evidence-based services. South Korea is addressing appropriate prescribing, monitoring, and public awareness. The United Kingdom continues to integrate prescribing oversight, overdose prevention, and recovery services. The United States is focused on overdose mortality, treatment access, naloxone distribution, and safer pain-care practices.

Actions for Leaders: Prioritize Safety, Access, and Accountability

Industry leaders should build stewardship into product design, distribution, education, and post-market monitoring. Practical priorities include strengthening supply-chain controls, supporting tamper-resistant and abuse-deterrent approaches where clinically appropriate, improving traceability, expanding access to naloxone and evidence-based treatment, and partnering with health systems on responsible prescribing. Organizations should use AI only under documented governance, validate performance across affected populations, protect sensitive health data, and measure outcomes such as treatment continuity, preventable overdose, appropriate pain control, and equitable access. Engagement with regulators, clinicians, patients, and public-health agencies can improve implementation and trust.

Research Methodology: Evidence-Based Market Assessment

The assessment uses a structured review of the opioid-narcotics landscape across therapeutic use, dependence treatment, overdose prevention, regulation, technology, supply-chain controls, and health-system delivery. Findings are organized by the specified regions, country groups, and countries, with attention to differences in policy, infrastructure, epidemiology, and access. Interpretation should be grounded in authoritative regulatory publications, peer-reviewed research, public-health surveillance, clinical guidelines, and validated administrative or mortality data. Because conditions and policies change rapidly, conclusions should be refreshed against current national and international evidence before strategic decisions are made.

Conclusion: Responsible Opioid Stewardship Is the Strategic Imperative

The opioid-narcotics landscape is defined by a difficult balance: preserving access to legitimate pain care and dependence treatment while reducing diversion, unsafe use, and overdose. Sustainable progress requires coordinated regulation, resilient supply chains, evidence-based clinical practice, harm reduction, and equitable service delivery. Leaders that combine patient safety with access, transparent data governance, and measurable public-health outcomes will be better positioned to respond to changing risks across regions and health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Opioid Narcotics Market, by Route Of Administration
7.1. Introduction
7.2. Injectable
7.3. Nasal
7.4. Oral
7.5. Rectal
7.6. Transdermal
8. Opioid Narcotics Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Opioid Narcotics Market, by Molecule Type
9.1. Introduction
9.2. Fentanyl
9.3. Hydrocodone
9.4. Morphine
9.5. Oxycodone
10. Opioid Narcotics Market, by Formulation Type
10.1. Introduction
10.2. Extended Release
10.3. Immediate Release
11. Opioid Narcotics Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.3. Home Healthcare
11.4. Hospitals
12. Opioid Narcotics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Opioid Narcotics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Opioid Narcotics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Opioid Narcotics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AbbVie Inc.
17.2. Alembic Pharmaceuticals Ltd.
17.3. Alkem Laboratories Ltd.
17.4. AstraZeneca PLC
17.5. Bayer AG
17.6. Cipla Ltd.
17.7. Dr. Reddy’s Laboratories Ltd.
17.8. Eli Lilly and Company
17.9. Emcure Pharmaceuticals Ltd.
17.10. Endo Pharmaceuticals Inc.
17.11. GlaxoSmithKline plc
17.12. Hikma Pharmaceuticals plc
17.13. Indivior PLC
17.14. Intas Pharmaceuticals Ltd.
17.15. Johnson & Johnson Services, Inc.
17.16. Lupin Limited
17.17. Mallinckrodt Pharmaceuticals
17.18. Mylan N.V.
17.19. Novartis AG
17.20. Pfizer Inc.
17.21. Purdue Pharma L.P.
17.22. Sandoz International GmbH
17.23. Sanofi S.A.
17.24. Sun Pharmaceutical Industries Ltd.
17.25. Teva Pharmaceutical Industries Ltd.
17.26. Torrent Pharmaceuticals Ltd.
17.27. Viatris Inc.
17.28. Zydus Lifesciences Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Opioid Narcotics Market, Years Considered for the Study
FIGURE 2. Global Opioid Narcotics Market, Research Design
FIGURE 3. Global Opioid Narcotics Market, Research Framework
FIGURE 4. Global Opioid Narcotics Market, Data Triangulation
FIGURE 5. Global Opioid Narcotics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Opioid Narcotics Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 7. Global Opioid Narcotics Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Opioid Narcotics Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Opioid Narcotics Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Opioid Narcotics Market Size, by Molecule Type, 2025 vs 2032 (%)
FIGURE 11. Global Opioid Narcotics Market Size, by Molecule Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Opioid Narcotics Market Size, by Formulation Type, 2025 vs 2032 (%)
FIGURE 13. Global Opioid Narcotics Market Size, by Formulation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Opioid Narcotics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Opioid Narcotics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Opioid Narcotics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Opioid Narcotics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Opioid Narcotics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Opioid Narcotics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Opioid Narcotics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Opioid Narcotics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Opioid Narcotics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Opioid Narcotics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Opioid Narcotics Market Segmentation & Coverage
TABLE 2. Global Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 4. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Rectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Rectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Rectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 20. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 27. Global Fentanyl Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Fentanyl Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Fentanyl Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Hydrocodone Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Hydrocodone Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Hydrocodone Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Morphine Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Morphine Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Morphine Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Oxycodone Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Oxycodone Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Oxycodone Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 40. Global Extended Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Extended Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Extended Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 57. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. North America Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. North America Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 76. North America Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. North America Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 78. North America Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 79. North America Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. North America Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Latin America Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Latin America Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 83. Latin America Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Latin America Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 85. Latin America Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 86. Latin America Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Latin America Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Europe Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Europe Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 90. Europe Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Europe Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 92. Europe Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 93. Europe Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Europe Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Middle East Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Middle East Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 97. Middle East Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. Middle East Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 99. Middle East Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 100. Middle East Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Middle East Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Africa Opioid Narcotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Africa Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 104. Africa Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. Africa Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 106. Africa Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 107. Africa Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Africa Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Global Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. ASEAN Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 114. ASEAN Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 115. ASEAN Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. ASEAN Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. GCC Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 119. GCC Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. GCC Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 121. GCC Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 122. GCC Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. GCC Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. European Union Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. European Union Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 126. European Union Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. European Union Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 128. European Union Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 129. European Union Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. European Union Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. BRICS Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. BRICS Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. BRICS Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. BRICS Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 135. BRICS Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 136. BRICS Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. BRICS Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. G7 Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. G7 Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 140. G7 Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. G7 Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 142. G7 Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 143. G7 Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. G7 Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. NATO Opioid Narcotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. NATO Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 147. NATO Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. NATO Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 149. NATO Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 150. NATO Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. NATO Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Global Opioid Narcotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. United States Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 154. United States Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 155. United States Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. United States Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 157. United States Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 158. United States Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United States Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Canada Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 161. Canada Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 162. Canada Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Canada Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 164. Canada Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 165. Canada Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Canada Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Mexico Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 168. Mexico Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. Mexico Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Mexico Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 171. Mexico Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 172. Mexico Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Mexico Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Brazil Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 175. Brazil Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 176. Brazil Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Brazil Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 178. Brazil Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 179. Brazil Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Brazil Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. United Kingdom Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 182. United Kingdom Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 183. United Kingdom Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. United Kingdom Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 185. United Kingdom Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 186. United Kingdom Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. United Kingdom Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Germany Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 189. Germany Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. Germany Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Germany Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 192. Germany Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 193. Germany Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Germany Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. France Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 196. France Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 197. France Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. France Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 199. France Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 200. France Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. France Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Russia Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 203. Russia Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 204. Russia Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Russia Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 206. Russia Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 207. Russia Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Russia Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Italy Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 210. Italy Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. Italy Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Italy Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 213. Italy Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 214. Italy Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Italy Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Spain Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 217. Spain Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 218. Spain Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Spain Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 220. Spain Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 221. Spain Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Spain Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. China Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 224. China Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. China Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. China Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 227. China Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 228. China Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. China Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. India Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 231. India Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. India Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. India Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 234. India Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 235. India Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. India Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Japan Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 238. Japan Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. Japan Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Japan Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 241. Japan Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 242. Japan Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Japan Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Australia Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 245. Australia Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 246. Australia Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. Australia Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 248. Australia Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 249. Australia Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Australia Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. South Korea Opioid Narcotics Market Size, 2017-2032 (USD Million)
TABLE 252. South Korea Opioid Narcotics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 253. South Korea Opioid Narcotics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. South Korea Opioid Narcotics Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 255. South Korea Opioid Narcotics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 256. South Korea Opioid Narcotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. South Korea Opioid Narcotics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. Global Opioid Narcotics Market Share, by Key Player, 2025
TABLE 259. Global Opioid Narcotics Market, Key Experts

Companies Mentioned

  • AbbVie Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Ltd.
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Emcure Pharmaceuticals Ltd.
  • Endo Pharmaceuticals Inc.
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Indivior PLC
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Opioid Use Disorder Treatment Market - Forecast from 2026 to 2031 - Product Image

Opioid Use Disorder Treatment Market - Forecast from 2026 to 2031

  • Report
  • 150 Pages
  • Global
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032 - Product Image

Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Opioids Market - Global Forecast 2026-2032 - Product Image

Opioids Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.